Liyuan Tao1, Ruitong Wang2, Na Han3, Jihong Liu4, Chuanxiang Yuan5, Lixia Deng6, Chunhua Han7, Fenglan Sun8, Min Liu2, Jue Liu2,9. 1. Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China. 2. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China. 3. Department of Obstetrics, Tongzhou Maternal and Child Health Hospital, Beijing, China. 4. Department of Obstetrics, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China. 5. Department of Obstetrics, Qianjiang Maternal and Child Health Hospital, Qianjiang City, Hubei Province, China. 6. Department of Obstetrics, Qianjiang Central Hospital, Qianjiang City, Hubei Province, China. 7. Department of Obstetrics, Qujing Maternal and Child Health Hospital, Qujing City, Yunnan Province, China. 8. Department of Obstetrics, Shexian Maternal and Child Health Hospital, Shexian City, Hebei Province, China. 9. National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.
Abstract
Background: Vaccine hesitancy has been recognized as an urgent public health issue. We aimed to explore the acceptance of a COVID-19 vaccine and related factors among pregnant women, a vulnerable population for vaccine-preventable diseases. Methods: A multi-center cross-sectional study among pregnant women was conducted in five provinces of mainland China from November 13 to 27, 2020. We collected sociodemographic characteristics, attitude, knowledge, and health beliefs on COVID-19 vaccination. Locally weighted scatterplot smoothing regression analysis was used to assess the trends of vaccination acceptance. Multivariable logistic regression was performed to identify factors related to vaccination acceptance. Results: Among the 1392 pregnant women, the acceptance rate of a COVID-19 vaccine were 77.4% (95%CI 75.1-79.5%). In the multivariable regression model, the acceptance rate was associated with young age (aOR = 1.87, 95% CI: 1.20-2.93), western region (aOR = 2.73, 95% CI: 1.72-4.32), low level of education (aOR = 2.49, 95% CI: 1.13-5.51), late pregnancy (aOR = 1.49, 95% CI: 1.03-2.16), high knowledge score on COVID-19 (aOR = 1.05, 95% CI: 1.01-1.10), high level of perceived susceptibility (aOR = 2.18, 95% CI: 1.36-3.49), low level of perceived barriers (aOR = 4.76, 95% CI: 2.23-10.18), high level of perceived benefit (aOR = 2.18, 95% CI: 1.36-3.49), and high level of perceived cues to action (aOR = 15.70, 95% CI: 8.28-29.80).Conclusions: About one quarters of pregnant women have vaccine hesitancy. Our findings highlight that targeted and multipronged efforts are needed to build vaccine literacy and confidence to increase the acceptance of a COVID-19 vaccine during the COVID-19 pandemic, especially for vulnerable populations.
Background: Vaccine hesitancy has been recognized as an urgent public health issue. We aimed to explore the acceptance of a COVID-19 vaccine and related factors among pregnant women, a vulnerable population for vaccine-preventable diseases. Methods: A multi-center cross-sectional study among pregnant women was conducted in five provinces of mainland China from November 13 to 27, 2020. We collected sociodemographic characteristics, attitude, knowledge, and health beliefs on COVID-19 vaccination. Locally weighted scatterplot smoothing regression analysis was used to assess the trends of vaccination acceptance. Multivariable logistic regression was performed to identify factors related to vaccination acceptance. Results: Among the 1392 pregnant women, the acceptance rate of a COVID-19 vaccine were 77.4% (95%CI 75.1-79.5%). In the multivariable regression model, the acceptance rate was associated with young age (aOR = 1.87, 95% CI: 1.20-2.93), western region (aOR = 2.73, 95% CI: 1.72-4.32), low level of education (aOR = 2.49, 95% CI: 1.13-5.51), late pregnancy (aOR = 1.49, 95% CI: 1.03-2.16), high knowledge score on COVID-19 (aOR = 1.05, 95% CI: 1.01-1.10), high level of perceived susceptibility (aOR = 2.18, 95% CI: 1.36-3.49), low level of perceived barriers (aOR = 4.76, 95% CI: 2.23-10.18), high level of perceived benefit (aOR = 2.18, 95% CI: 1.36-3.49), and high level of perceived cues to action (aOR = 15.70, 95% CI: 8.28-29.80).Conclusions: About one quarters of pregnant women have vaccine hesitancy. Our findings highlight that targeted and multipronged efforts are needed to build vaccine literacy and confidence to increase the acceptance of a COVID-19 vaccine during the COVID-19 pandemic, especially for vulnerable populations.
Authors: Philip J Smith; Sharon G Humiston; Edgar K Marcuse; Zhen Zhao; Christina G Dorell; Cynthia Howes; Beth Hibbs Journal: Public Health Rep Date: 2011 Jul-Aug Impact factor: 2.792
Authors: Mark G Thompson; Jeffrey C Kwong; Annette K Regan; Mark A Katz; Steven J Drews; Eduardo Azziz-Baumgartner; Nicola P Klein; Hannah Chung; Paul V Effler; Becca S Feldman; Kimberley Simmonds; Brandy E Wyant; Fatimah S Dawood; Michael L Jackson; Deshayne B Fell; Avram Levy; Noam Barda; Lawrence W Svenson; Rebecca V Fink; Sarah W Ball; Allison Naleway Journal: Clin Infect Dis Date: 2019-04-24 Impact factor: 9.079
Authors: Marc Brisson; Élodie Bénard; Mélanie Drolet; Johannes A Bogaards; Iacopo Baussano; Simopekka Vänskä; Mark Jit; Marie-Claude Boily; Megan A Smith; Johannes Berkhof; Karen Canfell; Harrell W Chesson; Emily A Burger; Yoon H Choi; Birgitte Freiesleben De Blasio; Sake J De Vlas; Giorgio Guzzetta; Jan A C Hontelez; Johannes Horn; Martin R Jepsen; Jane J Kim; Fulvio Lazzarato; Suzette M Matthijsse; Rafael Mikolajczyk; Andrew Pavelyev; Matthew Pillsbury; Leigh Anne Shafer; Stephen P Tully; Hugo C Turner; Cara Usher; Cathal Walsh Journal: Lancet Public Health Date: 2016-09-27
Authors: Heidi J Larson; Alexandre de Figueiredo; Zhao Xiahong; William S Schulz; Pierre Verger; Iain G Johnston; Alex R Cook; Nick S Jones Journal: EBioMedicine Date: 2016-09-13 Impact factor: 8.143
Authors: Jeffrey V Lazarus; Scott C Ratzan; Adam Palayew; Lawrence O Gostin; Heidi J Larson; Kenneth Rabin; Spencer Kimball; Ayman El-Mohandes Journal: Nat Med Date: 2020-10-20 Impact factor: 53.440
Authors: Abanoub Riad; Anna Jouzová; Batuhan Üstün; Eliška Lagová; Lukáš Hruban; Petr Janků; Andrea Pokorná; Jitka Klugarová; Michal Koščík; Miloslav Klugar Journal: Int J Environ Res Public Health Date: 2021-12-19 Impact factor: 3.390